PNC Financial Services Group
MPLT

PNC Financial Services Group’s MapLight Therapeutics MPLT Stock Holding History

PNC Financial Services Group’s Portfolio MPLT Stock Details MPLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.37K Buy
+94
New +$2.7K ﹤0.01% 4529

Other funds holding MPLT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
MSWMA
Market Street Wealth Management Advisors Indianapolis, Indiana $703M AUM 16.2% 1-Year Est. Return
MPW
MA Private Wealth San Carlos, California $671M AUM 23.37% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

PNC Financial Services Group's MPLT Position: Q2 2026 in Review

PNC Financial Services Group opened a new position in MapLight Therapeutics (MPLT) in Q2 2026: 94 shares worth $3.37K. The stake represents ﹤0.01% of the portfolio and ranks #4529 among its holdings.

25 funds tracked by Wall St. Rank hold MPLT as of Q2 2026.

  • PNC Financial Services Group held 94 shares of MapLight Therapeutics worth $3.37K as of Q2 2026.
  • MapLight Therapeutics was a new PNC Financial Services Group position in Q2 2026.
  • MapLight Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4529 holding.
  • 25 funds tracked by Wall St. Rank held MapLight Therapeutics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.